What does europe — revenue mean?

The total amount of money earned from business activities conducted specifically within the European market.

How do you interpret europe — revenue?

An increase indicates growing market demand, successful product launches, or expanded distribution in Europe, while a decrease may signal competitive pressure, regulatory hurdles, or declining market interest.

How does europe — revenue compare across companies?

Comparable to regional revenue reporting for other biopharmaceutical companies, often benchmarked against total international revenue or specific EU-market performance metrics of peers.

Summit Therapeutics SMMT Europe — Revenue

Discontinued — last reported Q4 '20

Similar metrics at other companies

BMRNEurope — Revenue

$115.5M-4.7%

MRNAEurope — Total Revenue

$13.25M-91.1%

EXELEurope — Total revenues

$39.57M+21.0%

INCYEurope — Total revenues

$92.43M+34.7%

ILMNEurope — Revenue

$353M+8.3%

RVTYEurope — Segment revenue

$223.05M+22.7%

Other financials

Income statement

See full

Revenue-—

Operating income-$65.6M-81.2%

Net income-$189.4M-201%

EPS (diluted)-$0.24-167%

Balance sheet

See full

Cash & equivalents$8.2M+7.2%

Total debt$20.0M+211%

Total equity$545.9M+58.5%

Total assets$647.9M+68.8%

Cash flow

See full

Operating cash flow-$122.3M-99.9%

CapEx$245.0K-41.9%

Free cash flow-$122.5M-99.0%

Valuation

See full

Market cap$10.67B+3.3%

Enterprise value$10.68B+3.4%

Profitability

See full

Operating margin-268,266.8%-272,316pp

Net margin-271,685%-275,966pp

FCF margin-5,931.6%+4,730pp

Returns & leverage

See full

Return on equity-271%-1,725pp

Debt / equity0×0.0×

Current ratio7.4×-3.2×

Where this comes from

Reported directly by Summit Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Summit Therapeutics’s 10-K, filed March 31, 2021, on SEC EDGAR. View the filing →

Questions, answered.

What does europe — revenue mean?: The total amount of money earned from business activities conducted specifically within the European market.
How do you interpret europe — revenue?: An increase indicates growing market demand, successful product launches, or expanded distribution in Europe, while a decrease may signal competitive pressure, regulatory hurdles, or declining market interest.
How does europe — revenue compare across companies?: Comparable to regional revenue reporting for other biopharmaceutical companies, often benchmarked against total international revenue or specific EU-market performance metrics of peers.